Incyte faces delay on FDA’s Jakafi decision for cGVHD; Bayer’s Parkinson’s cell therapy enters the clinic – Endpoints News

Incyte faces delay on FDA’s Jakafi decision for cGVHD; Bayer’s Parkinson’s cell therapy enters the clinic – Endpoints News
Source: Google NewsPublished on 2021-06-08